What type of study is this?

September 5, 2025Medicine Science | International Medical JournalOpen Access

Evaluation of difficult-to-treat rheumatoid arthritis using EULAR definition: Prevalence and clinical determinants from a single-center cross-sectional study

View Full Paper

Ask AI

Bookmark

Authors

SBSevilay BatıbayIstanbul Eye Hospital RURezan Koçak UlucaköyMinistry of Health BÖBaki ÖzdemirGülhane Askerî Tıp Akademisi

Discussion

Member takes

Implication

Cross-sectional analysis reveals 6.9% prevalence of difficult-to-treat rheumatoid arthritis in patients, indicating significant clinical determinants.

Key Points

Overall prevalence of difficult-to-treat rheumatoid arthritis was found to be 6.9%, indicating a notable challenge in management.
Patients meeting the EULAR criteria for difficult-to-treat RA exhibited longer disease duration and higher inflammatory activity compared to non-D2T patients.
Assessment used validated instruments for various parameters like fibromyalgia and functional status to enhance reliability of findings.
Individualized treatment strategies are critical in managing difficult-to-treat rheumatoid arthritis, emphasizing a tailored approach.

Cite This Study

Batıbay et al. (2025) studied this question.

synapsesocial.com/papers/68bb4d276d6d5674bcd0133d https://doi.org/10.5455/medscience.2025.07.204

View Full Paper

Ask AI

Bookmark

Implication

Cross-sectional analysis reveals 6.9% prevalence of difficult-to-treat rheumatoid arthritis in patients, indicating significant clinical determinants.

Evaluation of difficult-to-treat rheumatoid arthritis using EULAR definition: Prevalence and clinical determinants from a single-center cross-sectional study

Discussion

Member takes

Implication

Key Points

Cite This Study

Evaluation of difficult-to-treat rheumatoid arthritis using EULAR definition: Prevalence and clinical determinants from a single-center cross-sectional study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider